NEW YORK (GenomeWeb News) – Greg Lucier, chairman and CEO of Invitrogen, will assume that some role following consummation of the firm’s merger with Applied Biosystems. Mark Stevenson, currently president and COO of ABI, will retain that role in the merged company, which will keep the ABI name. Tony White, chairman, president, and CEO of ABI parent Applera, will serve as a consultant to ABI following the deal.
 

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.